Variant report
Variant | esv3374922 |
---|---|
Chromosome Location | chr12:47144185-47145733 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs36132346 | chr12:47144805-47144806 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs375875216 | chr12:47144806-47144807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs56940786 | chr12:47144818-47144819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1468969 | chr12:47144856-47144857 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs575737230 | chr12:47144901-47144902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs546738505 | chr12:47144910-47144911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35061598 | chr12:47144923-47144924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78106358 | chr12:47144926-47144927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200675272 | chr12:47144940-47144941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372070668 | chr12:47144979-47144980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4768754 | chr12:47144982-47144983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs567178160 | chr12:47144987-47144988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12315315 | chr12:47144993-47144994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs181934962 | chr12:47144994-47144995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs4768755 | chr12:47145000-47145001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61567424 | chr12:47145224-47145225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs559497518 | chr12:47145269-47145270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527463572 | chr12:47145297-47145298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138436283 | chr12:47145328-47145329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564355878 | chr12:47145356-47145357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533405153 | chr12:47145370-47145371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190002938 | chr12:47145379-47145380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs142330771 | chr12:47145413-47145414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146434424 | chr12:47145417-47145418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549173872 | chr12:47145440-47145441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12426014 | chr12:47145441-47145442 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs79618521 | chr12:47145460-47145461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78652469 | chr12:47145485-47145486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577914615 | chr12:47145509-47145510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537302669 | chr12:47145511-47145512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2430914 | chr12:47145534-47145535 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs575915483 | chr12:47145561-47145562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181201549 | chr12:47145565-47145566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555145596 | chr12:47145606-47145607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs572237675 | chr12:47145618-47145619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186477859 | chr12:47145635-47145636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:47144800-47145000 | Enhancers | Primary T cells from cord blood | blood |
2 | chr12:47145200-47145600 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
3 | chr12:47145200-47146200 | Weak transcription | Primary T cells from cord blood | blood |
4 | chr12:47145200-47146200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr12:47145200-47146400 | Enhancers | Primary T helper cells fromperipheralblood | blood |
6 | chr12:47145200-47146800 | Enhancers | HepG2 | liver |
7 | chr12:47145600-47146000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
8 | chr12:47145600-47146200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |